What is the relation between gout and sleep apnea?

The honest answer is that the relationship between gout and obstructive sleep apnea is real, bidirectional, and mechanistically plausible, but the evidence base is thinner than the confidence of either the rheumatology or sleep medicine communities would suggest.

The core link is oxygen. In OSA, repeated airway collapse drops blood oxygen saturation, sometimes into the 70s and 80s. That hypoxia drives two things that matter for gout. First, it forces cells to break down ATP through the purine salvage pathway, and the end product of purine metabolism is uric acid. More hypoxia, more cell stress, more uric acid dumped into the blood. Second, hypoxia triggers inflammation and oxidative stress, which impairs the kidney's ability to excrete urate. Both mechanisms push serum urate up, and serum urate is the direct precursor to monosodium urate crystal deposition in joints. That is the gout attack. The 2012 positional study in the records [1] shows how common OSA is in the general sleep clinic population, with a mean supine AHI of 21.6 events per hour, but it does not track urate. The 2004 nursing review [2] describes the clinical phenotype of OSA patients, older, heavier, snoring, daytime sleepiness, but again no urate data. Neither study measures the other side of the equation.

The reverse direction is also plausible. Gout is a systemic inflammatory disease. Chronic inflammation from gouty arthritis can worsen upper airway collapsibility through local soft tissue edema in the pharynx, and systemic inflammation can destabilize respiratory drive. But this direction has almost no direct human evidence. What exists is epidemiological: people with gout have a higher prevalence of OSA, and people with OSA have higher serum urate. The strongest data on the treatment side is that CPAP therapy lowers serum urate in some small trials, with reductions of about 0.5 to 1.0 mg/dL, but those trials are short, mostly under three months, and almost all are industry-funded or small academic cohorts. No trial has ever randomized patients with both conditions to CPAP versus no CPAP and measured gout flares as the primary outcome. That is the gap. The mechanism is coherent, the association is consistent, but the causal chain from OSA to gout attack is inferred, not proven.

The clinical implication is practical. If a patient has gout and snores heavily, or is obese and sleepy, the urate-lowering drug will not fix the apnea. The apnea will keep driving urate production. Conversely, treating the apnea with CPAP may help the gout, but the effect size is modest and the evidence is weak. The honest call is that every gout patient with obesity, snoring, or daytime sleepiness should be screened for OSA, not because the gout proves the apnea, but because the two conditions share a metabolic soil and treating one without the other is incomplete medicine. The evidence does not support the claim that CPAP cures gout, and it does not support the claim that gout causes OSA. It supports the claim that they travel together, and that the burden of proof is on the clinician who ignores one while treating the other.

Confidence: high that the association is real and mechanistically plausible; low that any specific treatment pathway has been proven to alter the course of both diseases. The long-term safety and efficacy data on CPAP for gout outcomes simply does not exist.